Saturday, November 21, 2026

U.S. Radiology Giant Posts 36% EBITDA Jump, Offering AI Benchmark for Global Health Systems

RadNet's adjusted EBITDA rose 36.3% year-over-year in Q1 2026, well ahead of its 22.1% revenue growth, driven by AI scheduling and diagnostic tools across its U.S. network. Advanced imaging volumes surged, with PET/CT up 35.2% and MRI same-center volume up 10.1%. The margin expansion offers a concrete financial reference point for hospital systems worldwide evaluating AI investment in radiology.

This article was written by AI. Published before our source requirement (10 August 2026); sources were not recorded. How we work

U.S. Radiology Giant Posts 36% EBITDA Jump, Offering AI Benchmark for Global Health Systems
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

RadNet's adjusted EBITDA grew 36.3% year-over-year in Q1 2026, outpacing revenue growth of 22.1%.1 The gap is a margin story, not just a volume one, and it is drawing attention beyond the United States.

Advanced imaging's share of procedural volume rose from 26.9% to 29.3%.1 PET/CT volume climbed 35.2%. MRI same-center volume increased 10.1%, well above the industry baseline.

RadNet credited TechLive, its AI scheduling platform, as a direct driver of MRI utilization gains.1 TechLive fills appointment gaps and reduces scanner downtime, converting idle capacity into billable procedures. Imaging center EBITDA margin improved 188 basis points year-over-year.1

DeepHealth, RadNet's AI diagnostic suite, assists radiologists by flagging findings and prioritizing worklists.1 The two platforms address opposite ends of the workflow: TechLive handles scheduling, DeepHealth handles reading and reporting.

The results arrive as health systems globally struggle with imaging backlogs. The UK's NHS faces radiology wait times exceeding six weeks for many scans. Germany, Japan, and Australia are each investing in AI-assisted diagnostics to address radiologist shortages. RadNet's Q1 data gives those conversations a financial reference point.

The pattern is consistent with what AI deployment looks like at scale: scheduling optimization cuts per-scan overhead; diagnostic AI compresses read times. Both effects compound across a large multi-site network.

Whether TechLive and DeepHealth are the primary causal drivers, rather than volume mix or favorable market conditions, has not been formally isolated.1 A center-by-center comparison of fully deployed versus rollout-phase locations would clarify the contribution. RadNet has not published that breakdown.

What Q1 2026 does establish: a large radiology operator running AI across scheduling and diagnostics is producing margin expansion that volume growth alone does not explain. For hospital networks from London to Tokyo evaluating AI investment, that is a concrete benchmark.

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 15 May 2026
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

Via News Editorial Team

The Via News Editorial Team writes analysis and news from the Via News source-traceability system, under the editorial responsibility of L. Miguel Salvado, Editor. Each article is built only from source documents we hold and lists them at the end, so every claim can be checked. Articles generated with AI say so under the byline, as the EU AI Act requires.